Article

Alcon files initial public offering with SEC

Fort Worth, TX-Alcon Inc., the wholly owned eye-care business of Nestle .A., Vevey, Switzerland, is making preparations to conduct an initial public offering (IPO). The transaction is expected to be complete by April 1.

Related Videos
(Image credit: Ophthalmology Times) NeuroOp Guru: The role of muscle biopsy in heteroplasmy detection
(Image credit: Ophthalmology Times) AGS 2025: Achieving success as an academic ophthalmologist with Thomas V. Johnson III, MD, PhD
(Image credit: Ophthalmology Times) AGS 2025: Constance Okeke, MD, highlights 1-year Streamline canaloplasty outcomes
(Image credit: Ophthalmology Times) AGS 2025: Telemedicine and genetics for resource-efficient care with Louis R. Pasquale, MD
Related Content
Harrow launches partnership with mail-order pharmacy, PhilRx to expand access to VEVYE
March 17th 2025

Harrow launches partnership with mail-order pharmacy, PhilRx to expand access to VEVYE

2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
December 13th 2024

California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco

Stealth BioTherapeutics reaches 50 percent enrollment target in phase 3 ReNEW study
March 17th 2025

Stealth BioTherapeutics reaches 50 percent enrollment target in phase 3 ReNEW study

EnVision Summit 2025: Advancing Ophthalmology and Optometry Together
November 19th 2024

Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025

Case report: Bilateral retinal detachments in a 19-year-old
March 17th 2025

Case report: Bilateral retinal detachments in a 19-year-old

ARVO announces recipients of the 2025 ARVO Foundation Early Career Clinician-Scientist Awards
March 16th 2025

ARVO announces recipients of the 2025 ARVO Foundation Early Career Clinician-Scientist Awards

© 2025 MJH Life Sciences

All rights reserved.